Category: Zacks Small Cap Research

12317710 / 1764 POSTS
By John Vandermosten, CFA NASDAQ:DYAI READ THE FULL DYAI RESEARCH REPORT Second Quarter 2022 Operational & Financial Results Dyadic International Inc. (NASDAQ:DYAI) provided second quarter 2022 operational and financial results in a press releas ...
By Thomas Kerr, CFA NASDAQ:NNBR READ THE FULL NNBR RESEARCH REPORT NN Inc. (NASDAQ:NNBR) reported 2nd quarter financial results on August 4th which were mostly below our expectations. Sales increased 1.8% despite the negative impacts of product disru ...
By M. Marin NASDAQ:NVX | OTC:NVNXF READ THE FULL NVX RESEARCH REPORT Company positioning to benefit from ramping growth in target verticals Novonix (NASDAQ:NVX) (OTC:NVNXF) has a positive sector tailwind, in our opinion, as it advances its strategy t ...
By David Bautz, PhD NASDAQ:MDNA READ THE FULL MDNA RESEARCH REPORT Business Update Update on ABILITY Trial; Unconfirmed Partial Response in Pancreatic Cancer Patient On August 9, 2022, Medicenna Therapeutics Corp. (NASDAQ:MDNA) filed a voluntary supp ...
By David Bautz, PhD NASDAQ:EPIX READ THE FULL EPIX RESEARCH REPORT Business Update Multiple Ongoing Studies of EPI-7386 ESSA Pharma Inc (NASDAQ:EPIX) is developing EPI-7386 as a treatment for prostate cancer. It is a member of a novel class of compou ...
By Lisa Thompson NASDAQ:POET READ THE FULL POET RESEARCH REPORT Despite the performance of the stock price, POET (NASDAQ:POET) continued to make technical progress in Q2 and attract more actual and potential customers. It announced the availability o ...
By John Vandermosten, CFA NASDAQ:LPCN READ THE FULL LPCN RESEARCH REPORT Second Quarter 2022 Financial and Operational Results On August 8, 2022 Lipocine (NASDAQ:LPCN) filed its second quarter 2022 Form 10-Q and posted its earnings release for the qu ...
By David Bautz, PhD NASDAQ:ARWR READ THE FULL ARWR RESEARCH REPORT Business Update Phase 1/2a Clinical Trials Underway for Pulmonary Disease Candidates In July 2022, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) announced the first subjects were dose ...
By Brad Sorensen, CFAOTC:CLMEF READ THE FULL CLMEF RESEARCH REPORT Calima Energy (OTC:CLMEF) is an Australian-based company operating oil wells in Canada. Calima is a production-focused energy company pursuing the exploration and development of oil a ...
By John Vandermosten, CFA NASDAQ:LTRN READ THE FULL LTRN RESEARCH REPORT Second Quarter 2022 Financial and Operational Results On August 8, 2022, Lantern Pharma, Inc. (NASDAQ:LTRN) announced 2Q:22 annual financial and operational results, filed its F ...
12317710 / 1764 POSTS